The UCLA Broad Stem Cell Research Center's Dr. Brigitte Gomperts describes research into a treatment for COVID-19 utilizing lung organoids derived from pluripotent stem cells that is made possible by funding from California's Stem Cell Agency - CIRM. (#36460)